Targeted Radionuclide Therapy for Patients with Metastatic Pheochromocytoma and Paraganglioma: From Low-Specific-Activity to High-Specific-Activity Iodine-131 Metaiodobenzylguanidi...

por Jimenez, Camilo, Erwin, William, Chasen, Beth
Publicado 2019

Temporary Balloon Occlusion of the Common Hepatic Artery for Yttrium-90 Glass Microspheres Administration in a Patient with Hepatocellular Cancer and Renal Insufficiency

por Smith, Justin, Murthy, Ravi, Lahoti, Amit, Odisio, Bruno, Avritscher, Rony, Chasen, Beth, Mahvash, Armeen
Publicado 2013

The Use of (68)Ga-DOTATATE PET/CT in the Non-invasive Diagnosis of Optic Nerve Sheath Meningioma: A Case Report

por Al Feghali, Karine A., Yeboa, Debra N., Chasen, Beth, Gule, Maria K., Johnson, Jason M., Chung, Caroline
Publicado 2018

Bone Windows for Distinguishing Malignant from Benign Primary Bone Tumors on FDG PET/CT

por Costelloe, Colleen M., Chuang, Hubert H., Chasen, Beth A., Pan, Tinsu, Fox, Patricia S., Bassett, Roland L., Madewell, John E.
Publicado 2013

Delayed FDG PET Provides Superior Glioblastoma Conspicuity Compared to Conventional Image Timing

por Johnson, Jason Michael, Chen, Melissa M., Rohren, Eric M., Prabhu, Sujit, Chasen, Beth, Mawlawi, Osama, Liu, Ho-Ling, Gule-Monroe, Maria Kristine
Publicado 2021

Temporary Reversal of Hepatoenteric Collaterals during (90)Y Radioembolization Planning and Administration

por Habibollahi, Peiman, Odisio, Bruno C., Gurusamy, Varshana, Kuban, Joshua D., Avritscher, Rony, Abdelsalam, Mohamed E., Chasen, Beth A., Murthy, Ravi, Mahvash, Armeen
Publicado 2022

Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model

por Mueller-Schoell, Anna, Puebla-Osorio, Nahum, Michelet, Robin, Green, Michael R., Künkele, Annette, Huisinga, Wilhelm, Strati, Paolo, Chasen, Beth, Neelapu, Sattva S., Yee, Cassian, Kloft, Charlotte
Publicado 2021

Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients

por Tetzlaff, Michael T., Nelson, Kelly C., Diab, Adi, Staerkel, Gregg A., Nagarajan, Priyadharsini, Torres-Cabala, Carlos A., Chasen, Beth A., Wargo, Jennifer A., Prieto, Victor G., Amaria, Rodabe N., Curry, Jonathan L.
Publicado 2018

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients

por Teyateeti, Ajalaya, Mahvash, Armeen, Long, James P, Abdelsalam, Mohamed E, Avritscher, Rony, Chasen, Beth, Kaseb, Ahmed O, Kuban, Joshua D, Murthy, Ravi, Odisio, Bruno C, Teyateeti, Achiraya, Macapinlac, Homer A, Kappadath, S Cheenu
Publicado 2020

Phase II study of Radium‐223 dichloride combined with hormonal therapy for hormone receptor‐positive, bone‐dominant metastatic breast cancer

por Ueno, Naoto T., Tahara, Rie K., Fujii, Takeo, Reuben, James M., Gao, Hui, Saigal, Babita, Lucci, Anthony, Iwase, Toshiaki, Ibrahim, Nuhad K., Damodaran, Senthil, Shen, Yu, Liu, Diane D., Hortobagyi, Gabriel N., Tripathy, Debu, Lim, Bora, Chasen, Beth A.
Publicado 2019

Symptom Diaries of Patients with Midgut Neuroendocrine Tumors Treated with (177)Lu-DOTATATE

por Strosberg, Jonathan R., Srirajaskanthan, Rajaventhan, El-Haddad, Ghassan, Wolin, Edward M., Chasen, Beth A., Kulke, Matthew H., Bushnell, David L., Caplin, Martyn E., Baum, Richard P., Hendifar, Andrew E., Öberg, Kjell, Ruszniewski, Philippe, Santoro, Paola, Broberg, Per, Leeuwenkamp, Oscar R., Krenning, Eric P.
Publicado 2021

A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by (90)Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma

por Kaseb, Ahmed Omar, Kappadath, S Cheenu, Lee, Sunyoung S, Raghav, Kanwal Pratap, Mohamed, Yehia I, Xiao, Lianchun, Morris, Jeffrey S, Ohaji, Chimela, Avritscher, Rony, Odisio, Bruno C, Kuban, Joshua, Abdelsalam, Mohamed E, Chasen, Beth, Elsayes, Khaled M, Elbanan, Mohamed, Wolff, Robert A, Yao, James C, Mahvash, Armeen
Publicado 2021

An open-label, single-arm pilot study of EUS-guided brachytherapy with phosphorus-32 microparticles in combination with gemcitabine +/- nab-paclitaxel in unresectable locally advan...

por Bhutani, Manoop S., Klapman, Jason B., Tuli, Richard, El-Haddad, Ghassan, Hoffe, Sarah, Wong, Franklin C. L., Chasen, Beth, Fogelman, David R., Lo, Simon K., Nissen, Nicholas N., Hendifar, Andrew E., Varadhachary, Gauri, Katz, Matthew H. G., Erwin, William D., Koay, Eugene J., Tamm, Eric P., Singh, Ben S., Mehta, Rutika, Wolff, Robert A., Soman, Ashish, Cazacu, Irina M., Herman, Joseph M.
Publicado 2019